Safecor Health (United States) has no DMF, CEP or site registration linked in our records. 50 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Safecor Health: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/safecor-health

Overview

Safecor Health is a pharmaceutical company headquartered in Columbus, United States.

FDA compliance signals

50 FDA enforcement records linked to this company.

  • recall — Class II2026-11-04

    Manufacturer is recalling batches due to co-mingled tablet.

  • recall — Class II2026-09-23

    Failed Stability Specifications

  • recall — Class II2026-09-23

    Failed Stability Specifications

  • recall — Class II2026-09-23

    Failed Stability Specifications

  • recall — Class II2026-09-23

    Failed Stability Specifications

  • recall — Class II2026-09-23

    Failed Stability Specifications

  • recall — Class II2026-09-23

    Failed Stability Specifications

  • 4832026-06-12

    Investigations of discrepancies, failures

  • 4832026-06-12

    Prepared for each batch, include complete information

  • recall — Class II2026-05-27

    Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.

  • recall — Class II2026-05-27

    Presence of a Foreign Substance; black particles observed in liquid

  • recall — Class II2025-12-10

    Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.

  • 4832025-10-28

    Procedures not in writing, fully followed

  • recall — Class II2025-03-12

    Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

  • recall — Class II2025-03-12

    Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

  • recall — Class II2025-03-12

    Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

  • recall — Class II2025-03-12

    Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

  • recall — Class II2025-03-12

    Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

  • recall — Class II2024-11-27

    cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

  • recall — Class II2024-11-27

    cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

  • recall — Class II2024-11-27

    cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

  • recall — Class II2024-11-27

    cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

  • recall — Class II2024-11-27

    cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

  • 4832024-06-24

    Equipment Design, Size and Location

  • 4832024-06-24

    Complaint Handling Procedure

  • 4832024-06-24

    Items to cover on annual reviews

  • recall — Class II2023-11-08

    CGMP Deviations: Recall due to the absence of USP CGMP compendial requirements.

  • warning_letter2023-09-05

    FDA Warning Letter (drug product)

  • 4832023-09-01

    Written records kept in individual logs

  • 4832023-09-01

    Absence of Written Procedures

  • 4832023-09-01

    Changes to Procedures Not Reviewed, Approved

  • 4832023-09-01

    Identity Testing of Each Component

  • 4832023-09-01

    Reprocessing/quality control unit

  • 4832023-09-01

    Sample size - test intervals

  • 4832023-09-01

    Investigations of discrepancies, failures

  • 4832023-03-16

    Investigations of discrepancies, failures

  • 4832023-03-16

    Packaging line inspection before use

  • 4832023-03-16

    Cleaning / Sanitizing / Maintenance

  • 4832023-03-16

    Complaint Investigation/Follow-Up Findings

  • 4832023-03-16

    Master production and control records, procedure

  • 4832023-03-16

    Establish reliability of supplier's C of A

  • 4832018-02-02

    Buildings of Suitable Size, Construction, Location

  • 4832018-02-02

    Procedures not in writing, fully followed

  • 4832018-02-02

    Protective Apparel Not Worn

  • 4832017-10-19

    Review of representative number of batches

  • 4832017-10-19

    Establish reliability of supplier's C of A

  • 4832017-10-19

    Reporting of adverse drug experience to FDA

  • 4832017-10-19

    Procedures not in writing, fully followed

  • 4832017-10-19

    Changes to Procedures Not Reviewed, Approved

  • 4832017-10-19

    Equipment for Environmental Control

For suppliers

Is this Safecor Health?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.